Clinical trial
Sunitinib in Treating Patients With Recurrent Malignant Gliomas
NCT00499473 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00499473 |
|---|---|
| Title | Sunitinib in Treating Patients With Recurrent Malignant Gliomas |
| Official title | A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Anaplastic Astrocytoma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Adult Oligodendroglioma, Adult Pineal Gland Astrocytoma |
| Intervention type | Drug, Other |
| Interventions | sunitinib malate, pharmacological study |
| Enrollment | 31 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Oct 1, 2014 |
| First posted | Jul 11, 2007 |
| Last update posted | Feb 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: